VEGFA and breast cancer: In line with these findings, a combination of rIL-25 and IL-17B silencing (siIL-17B) or a single chain against IL-25R could provide a strong inhibition in cancer progression along with decreased VEGF expression, reduced cell viability, and stimulated apoptosis in BC cells [88,89].